Phase 3 Gastric Carcinoma Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Gastric Carcinoma
RemeGen Co., Ltd.555 enrolled1 locationNCT07315750
Recruiting
Phase 2Phase 3
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Gastric CancerChemotherapyGastroesophageal Junction Adenocarcinoma+13 more
Ukrainian Society of Clinical Oncology150 enrolled2 locationsNCT06028737
Recruiting
Phase 3
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
Locally Advanced Gastric Carcinoma
Zhejiang University190 enrolled1 locationNCT05593458